Ultan McDermott

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£400,030

Jan 17 - Dec 19

The identification of genetic vulnerabilities in head and neck cancers for the development of novel therapies.

MRC award to Wellcome Sanger Institute and Ultan McDermott

£5,079,623

Mar 15 - Mar 21

MICA: Stratification in COloRectal cancer: from biology to Treatment prediction: S-CORT

MRC award to UNIVERSITY OF OXFORD and TIMOTHY MAUGHAN

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}